Statera Biopharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
STAB Over the counter 8731 https://www.staterabiopharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Statera Biopharma Inc

Statera Biopharma Signs Letter of Intent for Merger with Worksite Labs - Mar 15th, 2023 12:00 pm
Statera Biopharma Announces Completion of Application Process to Uplist to the OTCQB(R) Venture Marketplace - Jan 24th, 2023 2:45 pm
Statera Biopharma Receives Positive Nasdaq Listing Determination - Oct 27th, 2022 9:00 pm
Statera Biopharma Files Form 10-Q and Reaches Agreement with Silverback Capital and AVOF - Oct 21st, 2022 9:42 pm
Statera Biopharma Announces Signing of a Binding MOU with Holobeam Technologies to Gain Access to Holobeam’s Disruptive Diagnostic Imaging and Therapeutic Technology for Cancer Patients - Oct 17th, 2022 7:30 pm
Statera Biopharma Completes Fiscal 2021 Audit; Files Form 10-K - Oct 6th, 2022 10:10 pm
Statera Biopharma Receives Nasdaq Listing Determination; Hearing Requested to Address Filing Delinquency - Sep 9th, 2022 11:50 pm
Nasdaq Resumes Trading in Statera Biopharma, Inc. - Aug 26th, 2022 11:49 am
Statera Biopharma Receives Anticipated Notice of Additional Filing Delinquency from Nasdaq - Aug 25th, 2022 9:30 pm
Nasdaq Halts Statera Biopharma, Inc. - Aug 25th, 2022 3:48 pm
Statera Biopharma Announces BF Borgers CPA PC as Independent Registered Public Accounting Firm - Jun 14th, 2022 11:30 am